Whitney Ijem Analyst PerformanceAnalyst at CitigroupWhitney Ijem is a stock analyst at Citigroup in the medical sector, covering 30 publicly traded companies. Over the past year, Whitney Ijem has issued 49 stock ratings, including buy and hold recommendations. While full access to Whitney Ijem's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Whitney Ijem's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings86 Last 10 YearsBuy Recommendations87.21% 75 Buy RatingsCompanies Covered30 Unique Companies Ratings Distribution86RatingsDistribution of strong buy, buy, hold, and sell ratings by Whitney Ijem.RatingPercentageCount Strong Buy0.0%0 ratings Buy87.2%75 ratings Hold12.8%11 ratings Sell0.0%0 ratingsOut of 86 total stock ratings issued by Whitney Ijem at Citigroup, the majority (87.2%) have been Buy recommendations, followed by 12.8% Hold.Best & Worst CallsBest Call0000.0%PVLAFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%RAREFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ30 companiesWhitney Ijem, an analyst at Citigroup, currently covers 30 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical30 companies100.0%Whitney Ijem of Citigroup specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE25 companies83.3%MED - GENERIC DRG2 companies6.7%MED - DRUGS2 companies6.7%PHARMACEUTICAL PREPARATIONS1 company3.3% Whitney Ijem's Ratings History at Citigroup Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTENXTenax Therapeutics7/28/2026Initiated Coverage$16.19$35.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals6/16/2026Boost Price Target$89.70$151.00Buy$0.0000.00% ROINTLAIntellia Therapeutics6/16/2026Reiterated Rating$13.65$49.00Buy$0.0000.00% ROIBBIOBridgeBio Pharma6/3/2026Initiated Coverage$63.88$104.00Buy$0.0000.00% ROIOCGNOcugen5/27/2026Lower Price Target$1.34$11.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/22/2026Lower Price Target$53.59$111.00Buy$0.0000.00% ROINTLAIntellia Therapeutics5/12/2026Lower Price Target$14.42$49.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals5/7/2026Boost Price Target$94.42$143.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/7/2026Boost Price Target$54.12$116.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals5/5/2026Lower Price Target$429.85$436.00Hold$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. VRTXVertex Pharmaceuticals4/30/2026Lower Price Target$425.67$437.00Hold$0.0000.00% ROIWVEWAVE Life Sciences4/30/2026Lower Price Target$7.06$43.00Buy$0.0000.00% ROINTLAIntellia Therapeutics4/28/2026Boost Price Target$13.42$58.00Buy$0.0000.00% ROIPHARPharming Group4/10/2026Initiated Coverage$16.98$37.00Buy$0.0000.00% ROITSHATaysha Gene Therapies4/6/2026Boost Price Target$4.70$17.00Buy$0.0000.00% ROINGNENeurogene4/6/2026Lower Price Target$21.12$180.00Buy$0.0000.00% ROIGUTSFractyl Health3/26/2026Reiterated Rating$0.47$8.00Buy$0.0000.00% ROIOCGNOcugen3/17/2026Initiated Coverage$2.33$12.00Buy$0.0000.00% ROIWVEWAVE Life Sciences3/10/2026Boost Price Target$14.12$52.00Buy$0.0000.00% ROIARCTArcturus Therapeutics3/5/2026Lower Price Target$7.19$21.00Buy$0.0000.00% ROIPASGPassage Bio3/4/2026Lower Price Target$8.23$23.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Lower Price Target$13.94$48.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals3/2/2026Lower Price Target$93.65$140.00Buy$0.0000.00% ROINGNENeurogene2/27/2026Initiated Coverage$25.04Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical2/26/2026Boost Price Target$60.22$104.00Buy$0.0000.00% ROIBEAMBeam Therapeutics2/20/2026Initiated Coverage$27.88$74.00Buy$0.0000.00% ROIBEAMBeam Therapeutics2/20/2026Initiated Coverage$27.59$74.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical2/18/2026Lower Price Target$20.37$79.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals2/17/2026Boost Price Target$485.29$441.00Hold$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/17/2026Boost Price Target$314.00$429.00Buy$0.0000.00% ROIWVEWAVE Life Sciences2/3/2026Boost Price Target$13.43$43.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical1/20/2026Upgrade$54.59$98.00Buy$0.0000.00% ROIGUTSFractyl Health12/19/2025Reiterated Rating$2.26$8.00Buy$0.0000.00% ROITNYATenaya Therapeutics12/18/2025Lower Price Target$0.67$5.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics12/16/2025Boost Price Target$88.98$204.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals12/12/2025Boost Price Target$115.35$141.00Buy$0.0000.00% ROIWVEWAVE Life Sciences12/8/2025Boost Price Target$18.53$40.00Buy$0.0000.00% ROIGUTSFractyl Health11/21/2025Boost Price Target$1.38$8.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics11/13/2025Boost Price Target$80.96$148.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals11/10/2025Boost Price Target$97.65$114.00Buy$0.0000.00% ROIThe trade I’ve been waiting for since 2011 (Ad)Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle.Watch the free video briefing and learn the No. 1 trade to leverage rising goldPVLAPalvella Therapeutics10/9/2025Boost Price Target$74.85$90.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics8/19/2025Boost Price Target$49.50$66.00Buy$0.0000.00% ROIGBIOGeneration Bio8/18/2025Boost Price Target$6.29$10.00Buy$0.0000.00% ROIPASGPassage Bio8/14/2025Lower Price Target$7.06$67.00Buy$0.0000.00% ROIGUTSFractyl Health8/14/2025Lower Price Target$0.98$6.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical8/8/2025Lower Price Target$27.54$128.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals8/6/2025Lower Price Target$386.10$411.00Hold$0.0000.00% ROIWVEWAVE Life Sciences8/4/2025Initiated Coverage$8.63$19.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals8/1/2025Boost Price Target$395.69$415.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals7/25/2025Lower Price Target$3.19$10.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals7/18/2025Boost Price Target$90.36$105.00Buy$000.0000.00% ROITSHATaysha Gene Therapies6/3/2025Boost Price Target$2.79$11.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals6/3/2025Lower Price Target$2.77$11.00Buy$0.0000.00% ROINTLAIntellia Therapeutics6/3/2025Lower Price Target$7.16$54.00Buy$00.0000.00% ROITSHATaysha Gene Therapies5/16/2025Boost Price Target$2.56$9.00Buy$0.0000.00% ROIARCTArcturus Therapeutics5/13/2025Lower Price Target$12.65$66.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals5/12/2025Lower Price Target$7.29$34.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals4/8/2025Boost Price Target$54.96$92.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals3/21/2025Boost Price Target$282.02$390.00Buy$000.0000.00% ROIGBIOGeneration Bio3/17/2025Reiterated Rating$4.84$90.00Buy$0.0000.00% ROITNYATenaya Therapeutics3/13/2025Lower Price Target$0.64$6.00Buy$0.0000.00% ROIARCTArcturus Therapeutics3/10/2025Lower Price Target$13.98$68.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals3/3/2025Lower Price Target$9.45$36.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals2/27/2025Boost Price Target$53.12$81.00Buy$00.0000.00% ROIPVLAPalvella Therapeutics2/20/2025Initiated Coverage$20.97$39.00Buy$00.0000.00% ROIRAREUltragenyx Pharmaceutical2/18/2025Boost Price Target$42.49$136.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals2/18/2025Boost Price Target$256.45$385.00Buy$000.0000.00% ROIVRTXVertex Pharmaceuticals2/11/2025Upgrade$458.84$424.00Hold$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
